alendronate and vitamin d 2

alendronate has been researched along with vitamin d 2 in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (33.33)	29.6817
2010's	4 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Ghose, R	1
Iwamoto, J; Kanoko, T; Sato, Y; Satoh, K	1
Dalton, N; Fogelman, I; Fraser, WD; Hampson, G; Inaoui, R; Turner, C	1
Kõks, S; Laius, O; Maasalu, K; Märtson, A	1

Reviews

1 review(s) available for alendronate and vitamin d 2

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for alendronate and vitamin d 2

Article	Year
Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: a randomized controlled trial. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:7 Topics: Aged; Aged, 80 and over; Alendronate; Amino Acids; Bone Density; Bone Resorption; Calcium; Drug Therapy, Combination; Ergocalciferols; Female; Follow-Up Studies; Fractures, Spontaneous; Hip Fractures; Humans; Osteoporosis, Postmenopausal; Risk; Vitamin D Deficiency	2006

Article

Year

Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: a randomized controlled trial.

Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:7

Topics: Aged; Aged, 80 and over; Alendronate; Amino Acids; Bone Density; Bone Resorption; Calcium; Drug Therapy, Combination; Ergocalciferols; Female; Follow-Up Studies; Fractures, Spontaneous; Hip Fractures; Humans; Osteoporosis, Postmenopausal; Risk; Vitamin D Deficiency

2006

Other Studies

4 other study(ies) available for alendronate and vitamin d 2

Article	Year
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Osteomalacia: recovery of bone density. The New Zealand medical journal, 2004, Jun-18, Volume: 117, Issue:1196 Topics: 25-Hydroxyvitamin D 2; Absorptiometry, Photon; Aged; Alendronate; Alkaline Phosphatase; Back Pain; Bone Density; Calcium; Ergocalciferols; Female; Humans; Lumbar Vertebrae; Osteomalacia; Osteoporosis, Postmenopausal; Treatment Outcome	2004
Effect of a 300 000-IU loading dose of ergocalciferol (Vitamin D2) on circulating 1,25(OH)2-vitamin D and fibroblast growth factor-23 (FGF-23) in vitamin D insufficiency. The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:2 Topics: Aged; Alendronate; Bone Density; Bone Density Conservation Agents; Ergocalciferols; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Male; Middle Aged; Osteoporosis; Postmenopause; Vitamin D; Vitamin D Deficiency	2013
Use of drugs against osteoporosis in the Baltic countries during 2010-2014. Medicina (Kaunas, Lithuania), 2016, Volume: 52, Issue:5 Topics: Alendronate; Baltic States; Bone Density Conservation Agents; Calcium Channel Blockers; Denosumab; Diphosphonates; Drug Utilization; Ergocalciferols; Fractures, Bone; Humans; Ibandronic Acid; Osteoporosis; Risedronic Acid	2016